Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells

Piergiorgio Pettazzoni, Stefania Pizzimenti, Cristina Toaldo, Paula Sotomayor, Luigina Tagliavacca, Song Liu, Dan Wang, Rosalba Minelli, Leigh Ellis, Peter Atadja, Eric Ciamporcero, Mario Umberto Dianzani, Giuseppina Barrera, Roberto Pili

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Histone deacetylase inhibitors (HDACIs) are promising antineoplastic agents for the treatment of cancer. Here we report that the lipid peroxidation end product 4-hydroxynonenal (HNE) significantly potentiates the anti-tumor effects of the HDAC inhibitor panobinostat (LBH589) in the PC3 prostate cancer cell model. Panobinostat and HNE inhibited proliferation of PC3 cells and the combination of the two agents resulted in a significant combined effect. Cell cycle analysis revealed that both single agents and, to a greater extent, their combined treatment induced G2/M arrest, but cell death occurred in the combined treatment only. Furthermore, HNE and, to a greater extent, the combined treatment induced dephosphorylation of Cdc2 leading to progression into mitosis as confirmed by α-tubulin/DAPI staining and phospho-histone H3 (Ser10) analysis. To evaluate possible induction of DNA damage we utilized the marker phosphorylated histone H2A.X. Results showed that the combination of panobinostat and HNE induced significant DNA damage concomitant with the mitotic arrest. Then, by using androgen receptor (AR)-expressing PC3 cells we observed that the responsiveness to HNE and panobinostat was independent of the expression of functional AR. Taken together, our data suggest that HNE potentiates the antitumoral effect of the HDACI panobinostat in prostate cancer cells.

Original languageEnglish (US)
Pages (from-to)313-322
Number of pages10
JournalFree Radical Biology and Medicine
Volume50
Issue number2
DOIs
StatePublished - Jan 15 2011
Externally publishedYes

Fingerprint

Histone Deacetylase Inhibitors
Cell Cycle Checkpoints
Lipid Peroxidation
DNA Damage
Prostatic Neoplasms
Cells
Lipids
DNA
Androgen Receptors
Histones
Cell death
Tubulin
Mitosis
Antineoplastic Agents
4-hydroxy-2-nonenal
panobinostat
Tumors
Neoplasms
Cell Cycle
Cell Death

Keywords

  • Androgen receptor
  • DNA damage
  • Free radicals
  • HNE
  • Mitotic arrest
  • Panobinostat
  • Prostate cancer

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. / Pettazzoni, Piergiorgio; Pizzimenti, Stefania; Toaldo, Cristina; Sotomayor, Paula; Tagliavacca, Luigina; Liu, Song; Wang, Dan; Minelli, Rosalba; Ellis, Leigh; Atadja, Peter; Ciamporcero, Eric; Dianzani, Mario Umberto; Barrera, Giuseppina; Pili, Roberto.

In: Free Radical Biology and Medicine, Vol. 50, No. 2, 15.01.2011, p. 313-322.

Research output: Contribution to journalArticle

Pettazzoni, P, Pizzimenti, S, Toaldo, C, Sotomayor, P, Tagliavacca, L, Liu, S, Wang, D, Minelli, R, Ellis, L, Atadja, P, Ciamporcero, E, Dianzani, MU, Barrera, G & Pili, R 2011, 'Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells', Free Radical Biology and Medicine, vol. 50, no. 2, pp. 313-322. https://doi.org/10.1016/j.freeradbiomed.2010.11.011
Pettazzoni, Piergiorgio ; Pizzimenti, Stefania ; Toaldo, Cristina ; Sotomayor, Paula ; Tagliavacca, Luigina ; Liu, Song ; Wang, Dan ; Minelli, Rosalba ; Ellis, Leigh ; Atadja, Peter ; Ciamporcero, Eric ; Dianzani, Mario Umberto ; Barrera, Giuseppina ; Pili, Roberto. / Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. In: Free Radical Biology and Medicine. 2011 ; Vol. 50, No. 2. pp. 313-322.
@article{951af48cfe734d82a22b48bc30cac10d,
title = "Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells",
abstract = "Histone deacetylase inhibitors (HDACIs) are promising antineoplastic agents for the treatment of cancer. Here we report that the lipid peroxidation end product 4-hydroxynonenal (HNE) significantly potentiates the anti-tumor effects of the HDAC inhibitor panobinostat (LBH589) in the PC3 prostate cancer cell model. Panobinostat and HNE inhibited proliferation of PC3 cells and the combination of the two agents resulted in a significant combined effect. Cell cycle analysis revealed that both single agents and, to a greater extent, their combined treatment induced G2/M arrest, but cell death occurred in the combined treatment only. Furthermore, HNE and, to a greater extent, the combined treatment induced dephosphorylation of Cdc2 leading to progression into mitosis as confirmed by α-tubulin/DAPI staining and phospho-histone H3 (Ser10) analysis. To evaluate possible induction of DNA damage we utilized the marker phosphorylated histone H2A.X. Results showed that the combination of panobinostat and HNE induced significant DNA damage concomitant with the mitotic arrest. Then, by using androgen receptor (AR)-expressing PC3 cells we observed that the responsiveness to HNE and panobinostat was independent of the expression of functional AR. Taken together, our data suggest that HNE potentiates the antitumoral effect of the HDACI panobinostat in prostate cancer cells.",
keywords = "Androgen receptor, DNA damage, Free radicals, HNE, Mitotic arrest, Panobinostat, Prostate cancer",
author = "Piergiorgio Pettazzoni and Stefania Pizzimenti and Cristina Toaldo and Paula Sotomayor and Luigina Tagliavacca and Song Liu and Dan Wang and Rosalba Minelli and Leigh Ellis and Peter Atadja and Eric Ciamporcero and Dianzani, {Mario Umberto} and Giuseppina Barrera and Roberto Pili",
year = "2011",
month = "1",
day = "15",
doi = "10.1016/j.freeradbiomed.2010.11.011",
language = "English (US)",
volume = "50",
pages = "313--322",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells

AU - Pettazzoni, Piergiorgio

AU - Pizzimenti, Stefania

AU - Toaldo, Cristina

AU - Sotomayor, Paula

AU - Tagliavacca, Luigina

AU - Liu, Song

AU - Wang, Dan

AU - Minelli, Rosalba

AU - Ellis, Leigh

AU - Atadja, Peter

AU - Ciamporcero, Eric

AU - Dianzani, Mario Umberto

AU - Barrera, Giuseppina

AU - Pili, Roberto

PY - 2011/1/15

Y1 - 2011/1/15

N2 - Histone deacetylase inhibitors (HDACIs) are promising antineoplastic agents for the treatment of cancer. Here we report that the lipid peroxidation end product 4-hydroxynonenal (HNE) significantly potentiates the anti-tumor effects of the HDAC inhibitor panobinostat (LBH589) in the PC3 prostate cancer cell model. Panobinostat and HNE inhibited proliferation of PC3 cells and the combination of the two agents resulted in a significant combined effect. Cell cycle analysis revealed that both single agents and, to a greater extent, their combined treatment induced G2/M arrest, but cell death occurred in the combined treatment only. Furthermore, HNE and, to a greater extent, the combined treatment induced dephosphorylation of Cdc2 leading to progression into mitosis as confirmed by α-tubulin/DAPI staining and phospho-histone H3 (Ser10) analysis. To evaluate possible induction of DNA damage we utilized the marker phosphorylated histone H2A.X. Results showed that the combination of panobinostat and HNE induced significant DNA damage concomitant with the mitotic arrest. Then, by using androgen receptor (AR)-expressing PC3 cells we observed that the responsiveness to HNE and panobinostat was independent of the expression of functional AR. Taken together, our data suggest that HNE potentiates the antitumoral effect of the HDACI panobinostat in prostate cancer cells.

AB - Histone deacetylase inhibitors (HDACIs) are promising antineoplastic agents for the treatment of cancer. Here we report that the lipid peroxidation end product 4-hydroxynonenal (HNE) significantly potentiates the anti-tumor effects of the HDAC inhibitor panobinostat (LBH589) in the PC3 prostate cancer cell model. Panobinostat and HNE inhibited proliferation of PC3 cells and the combination of the two agents resulted in a significant combined effect. Cell cycle analysis revealed that both single agents and, to a greater extent, their combined treatment induced G2/M arrest, but cell death occurred in the combined treatment only. Furthermore, HNE and, to a greater extent, the combined treatment induced dephosphorylation of Cdc2 leading to progression into mitosis as confirmed by α-tubulin/DAPI staining and phospho-histone H3 (Ser10) analysis. To evaluate possible induction of DNA damage we utilized the marker phosphorylated histone H2A.X. Results showed that the combination of panobinostat and HNE induced significant DNA damage concomitant with the mitotic arrest. Then, by using androgen receptor (AR)-expressing PC3 cells we observed that the responsiveness to HNE and panobinostat was independent of the expression of functional AR. Taken together, our data suggest that HNE potentiates the antitumoral effect of the HDACI panobinostat in prostate cancer cells.

KW - Androgen receptor

KW - DNA damage

KW - Free radicals

KW - HNE

KW - Mitotic arrest

KW - Panobinostat

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=78651244903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651244903&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2010.11.011

DO - 10.1016/j.freeradbiomed.2010.11.011

M3 - Article

C2 - 21078383

AN - SCOPUS:78651244903

VL - 50

SP - 313

EP - 322

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 2

ER -